Healthcare execs understand the need to provide personalized care to patients. That’s why nine out of 10 biopharma executives agree that their industry will unanimously convert to using AI-backed marketing tools to ensure relevant engagement and personalization to HCPs within the next 3-5 years.
Yet, while most pharma executives realize the utility of data and analytics, there are gaps that prevent them from making full use of this technology. For example, some of the main problems this technology aims to solve — and how it solves them — include:
Thank you for your interest in the report! Click below to get your copy.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again